daunorubicin has been researched along with Adverse Drug Event in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (54.55) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Ding, D; Fang, H; Kelly, R; Liu, Z; Shi, Q; Tong, W | 1 |
| Adly, AAM; Ebeid, FSE; El-Ghoroury, E; Mostafa, M; Tantawy, AAG | 1 |
| Brandwein, JM; Gupta, V; Howson-Jan, K; Leber, BF; MacAlpine, K; Minden, MD; Moore, M; Schimmer, AD; Schuh, AC; Wright, J; Yee, KW | 1 |
| Chen, YH; Hu, DN; Kuo, HK; Wu, PC; Wu, YC; Yang, PM | 1 |
| Druet, P; Fillastre, JP; Méry, JP | 1 |
| Bouhour, JB; Chareyre, M; Godin, JF; Nicolas, G; Rozo, L | 1 |
| Oizumi, K; Oka, S | 1 |
| Berry, DH | 1 |
| Simone, J | 1 |
| Crosby, WH | 1 |
2 review(s) available for daunorubicin and Adverse Drug Event
| Article | Year |
|---|---|
[Drug-induced glomerular nephropathies].
Topics: Animals; Anti-Inflammatory Agents; Anticonvulsants; Daunorubicin; Disease Models, Animal; Doxorubicin; Drug-Related Side Effects and Adverse Reactions; Gold; Humans; Kidney Diseases; Kidney Glomerulus; Lithium; Mercury; Mitomycin; Mitomycins; Rats; Rats, Inbred Strains; Sulfhydryl Compounds | 1983 |
[Chemotherapy].
Topics: Anti-Bacterial Agents; Asparaginase; Bleomycin; Cephalosporins; Cytarabine; Daunorubicin; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Humans; Kanamycin; Penicillins; Rifampin; Vincristine | 1972 |
2 trial(s) available for daunorubicin and Adverse Drug Event
| Article | Year |
|---|---|
A phase I study of tipifarnib combined with conventional induction and consolidation therapy for previously untreated patients with acute myeloid leukemia aged 60 years and over.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Drug-Related Side Effects and Adverse Reactions; Gastrointestinal Diseases; Humans; Leukemia, Myeloid, Acute; Maximum Tolerated Dose; Middle Aged; Quinolones; Remission Induction | 2009 |
Acute lymphocytic leukemia in childhood.
Topics: Asparaginase; Black People; Bone Marrow Examination; Central Nervous System Diseases; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Immunosuppression Therapy; Infections; Injections, Spinal; Leukemia, Lymphoid; Leukopenia; Male; Methotrexate; Prednisone; Remission, Spontaneous; Vincristine | 1974 |
7 other study(ies) available for daunorubicin and Adverse Drug Event
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Models, Biological; Predictive Value of Tests | 2011 |
Influence of thiopurine methyltransferase gene polymorphism on Egyptian children with acute lymphoblastic leukaemia.
Topics: Adolescent; Alleles; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Daunorubicin; Drug-Related Side Effects and Adverse Reactions; Female; Genetic Association Studies; Genetic Predisposition to Disease; Genotype; Humans; Infant; Male; Mercaptopurine; Methyltransferases; Polymorphism, Single Nucleotide; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Vincristine | 2017 |
Effects of topoisomerase II inhibitors on retinal pigment epithelium and experimental proliferative vitreoretinopathy.
Topics: Animals; Cell Survival; Cells, Cultured; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Drug-Related Side Effects and Adverse Reactions; Enzyme Inhibitors; Etoposide; In Vitro Techniques; Injections; Male; Maximum Tolerated Dose; Pigment Epithelium of Eye; Rabbits; Topoisomerase II Inhibitors; Vitreoretinopathy, Proliferative; Vitreous Body | 2007 |
[The heart and drug poisoning, excluding cardiologic treatments].
Topics: Daunorubicin; Doxorubicin; Drug-Related Side Effects and Adverse Reactions; Emetine; Heart; Humans; Lithium; Myocarditis | 1978 |
The child with acute leukemia.
Topics: Age Factors; Asparaginase; Chickenpox; Child, Preschool; Counseling; Cyclophosphamide; Cytarabine; Cytomegalovirus Infections; Daunorubicin; Drug-Related Side Effects and Adverse Reactions; Humans; Injections, Spinal; Leukemia; Mercaptopurine; Methotrexate; Patient Care Planning; Pediatrics; Physician-Patient Relations; Prednisone; Prognosis; Sex Factors; Vincristine | 1974 |
Treatment of AGL.
Topics: Aminopterin; Cortisone; Cytarabine; Daunorubicin; Drug Tolerance; Drug-Related Side Effects and Adverse Reactions; Hemorrhage; Humans; Infections; Leukemia, Myeloid, Acute; Patient Isolators; Steroids; Transfusion Reaction | 1969 |